Johnson & Johnson ( J&J ) has reduced its Q3 profits from $ 4.8bn to $ 1.8bn , following a recent proposed $ 4bn opioid settlement payment . The drug industry faces roughly 2,600 lawsuits brought by state and local governments, hospitals and other entities seeking to hold drugmakers and distributors responsible for the toll of opioid abuse. J&J said it did not know when the settlement would be finalised , but would make any necessary accounting adjustments after the fact . Around 2,600 US lawsuits are outstanding against drug companies in relation to the opioid crisis .
Johnson & Johnson ( J&J ) has reduced its Q3 profits from $ 4.8bn to $ 1.8bn , following a recent proposed $ 4bn opioid settlement payment . J&J said it did not know when the settlement would be finalised , but would make any necessary accounting adjustments after the fact . Around 2,600 US lawsuits are outstanding against drug companies in relation to the opioid crisis .